ArticleThe pharmacogenomics journal2017

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

M Frías et al.PubMed ↗Publisher ↗

No numbers read from the abstract.